| NO |
Title |
Date |
Submission Obligator |
| 10 |
Notice on Change of CEO |
2021/03/26 |
HANALL BIOPHARMA CO.,LTD |
| 9 |
Outcome of Annual Shareholders' Meeting |
2021/03/26 |
HANALL BIOPHARMA CO.,LTD |
| 8 |
Reporting reasons for holding general shareholders' meeting on the most concentrated date |
2021/03/11 |
HANALL BIOPHARMA CO.,LTD |
| 7 |
Decision on Calling Shareholders' Meeting |
2021/03/10 |
HANALL BIOPHARMA CO.,LTD |
| 6 |
Submission of Audit Report |
2021/03/05 |
HANALL BIOPHARMA CO.,LTD |
| 5 |
Decision on Disposal Treasury Stocks |
2021/02/08 |
HANALL BIOPHARMA CO.,LTD |
| 4 |
Decision on Disposal Treasury Stocks |
2021/01/29 |
HANALL BIOPHARMA CO.,LTD |
| 3 |
30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) |
2021/01/19 |
HANALL BIOPHARMA CO.,LTD |
| 2 |
Interim Report on Business Performance(Fair Disclosure) |
2021/01/19 |
HANALL BIOPHARMA CO.,LTD |
| 1 |
[Revised]Organization of Investor Relations Event |
2020/12/21 |
HANALL BIOPHARMA CO.,LTD |